You are here

South Korea

Merck scoops up a PhII J&J discard in a bargain-basement deal. And this time they’re shooting at NASH

Endpoints

Tue, 08/4/20 - 12:42 pm

SK Biopharmaceuticals emerges from pandemic delays with pitch for $822M IPO

Endpoints

Mon, 06/15/20 - 11:01 am

SK Biopharmaceuticals

Takeda continues post-Shire selloff, inching closer to $10B goal

Endpoints

Thu, 06/11/20 - 12:16 pm

LegoChem Biosciences, Iksuda collaborate to develop antibody-drug conjugates

Pharmaceutical Business Review

Fri, 04/17/20 - 10:38 am

LegoChem Biosciences

antibody-drug conjugate

Celltrion plans to launch a biosimilar each year for next decade

Pharmaforum

Fri, 01/17/20 - 12:16 pm

SK Biopharmaceuticals IPO Tabbed to Raise $850 Million

Yahoo/Guru Focus

Tue, 12/3/19 - 10:20 am

SK Biopharmaceuticals

SK Biopharmaceuticals, fresh off an FDA nod, preps for $850M IPO in January: report

Fierce Pharma

Mon, 11/25/19 - 09:50 pm

SK Biopharmaceuticals

AstraZeneca commits $630M to Korean drug R&D push

Fierce Biotech

Mon, 06/17/19 - 09:58 am

Celltrion and Samsung duel shaping up as both pledge billions of dollars to biologics

Fierce Pharma

Fri, 05/17/19 - 07:28 pm

Samsung Bioepis

Gilead Inks $785 Million Deal With Yuhan for NASH Development

BioSpace

Mon, 01/7/19 - 11:16 am

Gilead Sciences

Seoul Bio Hub pioneers Korea's vision for successful biotech cluster

Korea Herald

Fri, 09/14/18 - 09:30 am

Janssen, Bayer to close South Korean plants due to limited demand

Fierce Pharma

Sat, 08/4/18 - 12:12 pm

drug manufacturing

Merck KGaA injects $47M into Asian manufacturing efforts

Biopharma Dive

Sat, 03/3/18 - 10:36 am

drug manufacturing

Novartis slapped with $49m fine over kickbacks

Drug Delivery Business News

Fri, 04/28/17 - 11:46 am

Novartis Shares Lower on Ex Dividend Trading, Reports of Kickbacks Fine In South Korea

TheStreet.com

Thu, 03/2/17 - 09:54 am

Novartis offices in South Korea raided over bribery concerns

Stat

Mon, 02/22/16 - 11:27 am

Sanofi, Hanmi seal diabetes license deal for up to $4.2 bln

Yahoo/Reuters

Thu, 11/5/15 - 09:47 am

Arena Pharmaceuticals Announces Marketing Approval in South Korea of BELVIQ® (lorcaserin HCl) for Weight Management

Yahoo

Tue, 02/3/15 - 10:26 am

Arena Pharmaceuticals

Ildong Pharmaceutical

Roche, Teva and AstraZeneca are all said to be in the mix to buy Celltrion

Fierce Pharma

Wed, 01/8/14 - 11:11 am

Teva Enters South Korean Drug Market in Bid to Grow in East Asia

Bloomberg

Mon, 12/17/12 - 01:14 pm

Handok Pharmaceuticals

Pages